Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 34.Ident. | Authors (with country if any) | Title |
---|---|---|
001058 | M. Lee [Canada] ; E. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | NEUROTOXINS RELEASED FROM INTERFERON-GAMMA-STIMULATED HUMAN ASTROCYTES |
001F50 | A. C. Ludolph [Allemagne] ; J. Kassubek [Allemagne] ; B. G. Landwehrmeyer [Allemagne] ; E. Mandelkow [Allemagne] ; E. Mandelkow [Allemagne] ; D. J. Burn [Royaume-Uni] ; D. Caparros-Lefebvre [France] ; K. A. Frey [États-Unis] ; J. G. De Yebenes [Espagne] ; T. Gasser [Allemagne] ; P. Heutink [Pays-Bas] ; G. Höglinger [Allemagne] ; Z. Jamrozik [Pologne] ; K. A. Jellinger [Autriche] ; A. Kazantsev [États-Unis] ; H. Kretzschmar [Allemagne] ; A. E. Lang [Canada] ; I. Litvan [États-Unis] ; J. J. Lucas [Espagne] ; P. L. Mcgeer [Canada] ; S. Melquist [États-Unis] ; W. Oertel [Allemagne] ; M. Otto [Allemagne] ; D. Paviour [Royaume-Uni] ; T. Reum [Allemagne] ; A. Saint-Raymond [Royaume-Uni] ; J. C. Steele ; M. Tolnay [Suisse] ; H. Tumani [Allemagne] ; J. C. Van Swieten [Pays-Bas] ; M. T. Vanier [France] ; J. Vonsattel [États-Unis] ; S. Wagner [Allemagne] ; Z. K. Wszolek [États-Unis] | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options |
002905 | J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys |
002D28 | Huw R. Morris [Royaume-Uni] ; John C. Steele ; Richard Crook [États-Unis] ; Fabienne Wavrant-De Vrieze [États-Unis] ; Luisa Onstead-Cardinale [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Nick W. Wood [Royaume-Uni] ; Matthew Farrer [États-Unis] ; Andrew J. Lees [Royaume-Uni] ; P. L. Mcgeer [Canada] ; Teepu Siddique [États-Unis] ; John Hardy [Royaume-Uni, États-Unis] ; Jordi Perez-Tur [États-Unis, Espagne] | Genome-wide analysis of the Parkinsonism-dementia complex of Guam |
003302 | K. Yasojima [Canada] ; W. W. Tourtellotte [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy |
003533 | C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Aβ42-Carboxy-Terminal-like Immunoreactivity Is Associated with Intracellular Neurofibrillary Tangles and Pick Bodies |
003A16 | E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
003A20 | C. Schwab [Canada] ; J. C. Steele [États-Unis] ; P. L. Mcgeer [Canada] | Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus |
003A40 | P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
003A43 | C. Schwab [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of β-amyloid protein |
003C58 | P. L. Mcgeer [Canada] ; C. Schwab [Canada] ; E. G. Mcgeer [Canada] ; R. L. Haddock ; J. C. Steele | Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam |
003C64 | C. Schwab [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam |
003C72 | C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
003D57 | Y. Aimi [Canada] ; P. L. Mcgeer [Canada] | Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons |
004059 | Max H. Walker [Canada] ; S. U. Kim [Canada] ; P. L. Mcgeer [Canada] | Complement and cytokine gene expression in cultured microglia derived from postmortem human brains |
004153 | A. Klegeris [Canada] ; P. L. Mcgeer [Canada] | Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants |
004213 | I. Tooyama [Canada, Japon] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada, Japon] ; H. Kimura [Japon] ; P. L. Mcgeer [Canada] | Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease |
004242 | I. Moroo [Japon] ; T. Yamada [Japon] ; H. Makino [Japon] ; I. Tooyama [Japon] ; P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] ; K. Hirayama [Japon] | Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease |
004301 | O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
004405 | T. Yamada [Canada] ; D. B. Calne [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Further observations on Tau-positive glia in the brains with progressive supranuclear palsy |
004443 | P. L. Mcgeer [Canada] ; E. G. Mcgeer | Neurotransmitters and their receptors in the basal ganglia |
004449 | I. Tooyama [Canada] ; T. Kawamata [Canada] ; D. Walker [Canada] ; T. Yamada [Canada] ; K. Hanai ; H. Kimura ; M. Iwane ; K. Igarashi ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease |
004462 | K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. Mcgeer | Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls |
004641 | T. Yamada [Canada] ; P. L. Mcgeer ; E. G. Mcgeer | Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins |
004657 | R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada] | Cerebral glucose metabolism in Parkinson's disease with and without dementia |
004905 | T. Yamada [Canada] ; H. Akiyama [Canada] ; P. L. Mcgeer [Canada] | Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d |
004929 | T. Yamada [Canada] ; P. L. Mcgeer [Canada] ; K. G. Baimbridge [Canada] ; E. G. Mcgeer [Canada] | Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K |
004962 | R. F. Peppard ; W. R. W. Martin [Canada] ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
004963 | A. Mcgeer [Canada] ; P. L. Mcgeer ; R. Harrop ; H. Akiyama ; H. Kamo | Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in alzheimer's disease |
004C23 | P. L. Mcgeer [Canada] ; S. Itagaki [Canada] ; E. G. Mcgeer [Canada] | Expression of the histocompatibility glycoprotein HLA-DR in neurological disease |
004F49 | E. G. Mcgeer [Canada] ; M. Norman [Canada] ; B. Boyes [Canada] ; J. O'Kusky [Canada] ; J. Suzuki [Canada] ; P. L. Mcgeer [Canada] | Acetylcholine and aromatic amine systems in postmortem brain of an infant with Down's syndrome |
005355 | E. G. Mcgeer [Canada] ; J. Parkinson [Canada] ; P. L. Mcgeer [Canada] | Neonatal enzymic development in the interpeduncular nucleus and surrounding ventral tegmentum |
005482 | E. G. Mcgeer [Canada] ; H. C. Fibiger [Canada] ; P. L. Mcgeer [Canada] ; V. Wickson [Canada] | Aging and brain enzymes |
005490 | P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] ; J. A. Wada [Canada] ; E. Jung [Canada] | Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase |
This area was generated with Dilib version V0.6.29. |